Composed of a series of four guides, the OBIO Talent Toolkit stems from the success of the OBIO Health to Business Bridge (H2BB™) program which addresses an expressed need for more talent in the health science industry.
OBIO’s 2019 report describes an early adopter model to facilitate the evaluation and adoption of innovative health technologies in Ontario health organizations.
OBIO’s report, Realizing the Promise of Health Care Innovation: Increasing Value for the Patient, Health System and Economy, was published in 2013 and is a product of the Ontario Bioscience Economic Strategy Team (OBEST®), an initiative launched by OBIO to address the challenges faced by Ontario’s human health technology and bioscience industry.
OBIO’s 2018 Industry Consultation reports five recommendations from health science company executives on how to create the conditions for the growth of Ontario’s health science industry.
Over the past several months, OBESTTM has engaged >200 senior representatives from major stakeholder groups across Ontario’s life-sciences sector. The 6-month strategic planning process has resulted in defined priorities and a plan for robust growth and commercial viability of the province’s bioscience industry.